These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10654327)

  • 1. Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat.
    Knoll S; Alon US
    Pediatr Nephrol; 2000 Jan; 14(1):32-5. PubMed ID: 10654327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age on furosemide-induced nephrocalcinosis in the rat.
    Osorio AV; Alon MM; Nichols MA; Alon US
    Biol Neonate; 1998; 73(5):306-12. PubMed ID: 9573460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat.
    Alon US; Kaplan RA; Gratny LL; Nichols MA
    Pediatr Nephrol; 1996 Apr; 10(2):191-4. PubMed ID: 8703710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat.
    Pattaragarn A; Fox J; Alon US
    Kidney Int; 2004 May; 65(5):1684-9. PubMed ID: 15086907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt supplementation, growth, and nephrocalcinosis in the furosemide-treated weanling rat.
    Gratny LL; Ringer K; Hall RT; Alon US
    Biol Neonate; 1997; 71(1):37-45. PubMed ID: 8996656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of calbindin-D28k on renal calcium and magnesium handling during treatment with loop and thiazide diuretics.
    Lee CT; Ng HY; Lee YT; Lai LW; Lien YH
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F230-6. PubMed ID: 26582761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an animal model of nephrocalcinosis via selective dietary sodium and chloride depletion.
    Tuchman S; Asico LD; Escano C; Bobb DA; Ray PE
    Pediatr Res; 2013 Feb; 73(2):194-200. PubMed ID: 23174703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular mechanism for the spontaneous hypercalciuria in laboratory rat.
    Lau K; Eby BK
    J Clin Invest; 1982 Oct; 70(4):835-44. PubMed ID: 6288772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Chlorothiazide Versus Enteral Metolazone to Augment Loop Diuretic Therapy in the Intensive Care Unit.
    Michaud CJ; Mintus KC
    Ann Pharmacother; 2017 Apr; 51(4):286-292. PubMed ID: 28228057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants.
    Gimpel C; Krause A; Franck P; Krueger M; von Schnakenburg C
    Pediatr Int; 2010 Feb; 52(1):51-6. PubMed ID: 19460127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron.
    Edwards BR; Baer PG; Sutton RA; Dirks JH
    J Clin Invest; 1973 Oct; 52(10):2418-27. PubMed ID: 4729040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia.
    Seikaly MG; Baum M
    Pediatrics; 2001 Jul; 108(1):E6. PubMed ID: 11433085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of nephrocalcinosis in premature infants treated with loop diuretics.
    Pope JC; Trusler LA; Klein AM; Walsh WF; Yared A; Brock JW
    J Urol; 1996 Aug; 156(2 Pt 2):709-12. PubMed ID: 8683766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of organic anion transporter 1 protein is induced by chronic furosemide or hydrochlorothiazide infusion in rat kidney.
    Kim GH; Na KY; Kim SY; Joo KW; Oh YK; Chae SW; Endou H; Han JS
    Nephrol Dial Transplant; 2003 Aug; 18(8):1505-11. PubMed ID: 12897087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the hypocalciuric action of chlorothiazide.
    Costanzo LS; Weiner IM
    J Clin Invest; 1974 Sep; 54(3):628-37. PubMed ID: 4853451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years.
    Downing GJ; Egelhoff JC; Daily DK; Thomas MK; Alon U
    J Pediatr; 1992 Apr; 120(4 Pt 1):599-604. PubMed ID: 1552401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diuretics on urinary oxalate, calcium, and sodium excretion in very low birth weight infants.
    Campfield T; Braden G; Flynn-Valone P; Powell S
    Pediatrics; 1997 Jun; 99(6):814-8. PubMed ID: 9164775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up.
    Saarela T; Lanning P; Koivisto M; Paavilainen T
    Eur J Pediatr; 1999 Aug; 158(8):668-72. PubMed ID: 10445348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrocalcinosis in rabbits--correlation of ultrasound, computed tomography, pathology and renal function.
    Cramer B; Husa L; Pushpanathan C
    Pediatr Radiol; 1998 Jan; 28(1):9-13. PubMed ID: 9426266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.